Selected as a 14th KIST Family Company, Securing a Collaboration Platform for Technology Advancement and Global Expansion
2026-01-20
본문
Ebiogen Inc. has been selected as a 14th KIST Family Company under the program operated by the Korea Institute of Science and Technology (KIST).
The KIST Family Company Program is a collaborative initiative designed to create shared outcomes by selecting small and mid-sized enterprises with innovative technological capabilities and strong growth potential in the global market. The program provides participating companies with technical support, commercialization assistance, and support for entering global markets.
Through this selection, Ebiogen expects to further refine and advance its innovative products and core technological capabilities by leveraging KIST’s professional technical support system. In addition, Ebiogen anticipates that utilizing KIST’s domestic and international academia–industry–research networks and global collaboration infrastructure will significantly support overseas market entry and the expansion of partnerships.
Ebiogen will continue to strengthen its technological competitiveness through strategic collaborations with research institutes and grow into a trusted, innovation-driven company in the global market.
- PREV Ebiogen Signs Technology Transfer Agreement with Ajou University, Secures Core Technology to Strengthen BAROSGEN Drug Detection Portfolio
- NEXT BAROSGEN Enters the Thai Market in Earnest… Establishes a Distributor Partnership with Hanasusu (Expected to Improve Living Environments in Thailand and Help Prevent Drug Exposure)